5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with daunorubicin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gill, DR; Higgins, CF; Hyde, SC; Kirk, J; Mintenig, GM; Sepulveda, FV; Valverde, MA | 1 |
1 other study(ies) available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and daunorubicin
Article | Year |
---|---|
Specific inhibitors distinguish the chloride channel and drug transporter functions associated with the human multidrug resistance P-glycoprotein.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Carrier Proteins; Cell Line; Chloride Channels; Cyclosporins; Daunorubicin; Drug Resistance; Electrophysiology; Humans; Membrane Glycoproteins; Mice; Nitrobenzoates; Transfection; Verapamil | 1993 |